Reagent Kit for Rapid Determination of Soluble Fibrin Monomer Complexes in Blood Plasma Using the o-Phenanthroline Method (RFMC Test) According to TU 21.20.23-067-05595541-2020

This reagent kit is intended for the rapid detection of soluble fibrin monomer complexes (RFMC) in human plasma using the o-phenanthroline method, in accordance with technical specifications TU 21.20.23-067-05595541-2020.

I. RFMC Test – Available Versions:

Version 1

Catalog No.: PG-120-phenanthroline
Phenanthroline, dry (100 mg per vial) – 4 vials
Positive control, lyophilized (reconstituted volume 1.0 mL per vial) – 1 vial
Negative control, lyophilized (reconstituted volume 1.0 mL per vial) – 1 vial

Version 2

Catalog No.: PG-12/10-phenanthroline
Phenanthroline, lyophilized (reconstituted volume 5.0 mL per vial) – 4 vials
Positive control, lyophilized (reconstituted volume 1.0 mL per vial) – 1 vial
Negative control, lyophilized (reconstituted volume 1.0 mL per vial) – 1 vial

Version 3

Catalog No.: PG-12/20-phenanthroline
Phenanthroline, lyophilized (reconstituted volume 3.0 mL per vial) – 4 vials
Positive control, lyophilized (reconstituted volume 1.0 mL per vial) – 1 vial
Negative control, lyophilized (reconstituted volume 1.0 mL per vial) – 1 vial

II. Instructions for Use

III. Medical Device Passport

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Rapid Determination of Soluble Fibrin Monomer Complexes in Blood Plasma Using the o-Phenanthroline Method (RFMC Test) According to TU 21.20.23-067-05595541-2020, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back